Summit Therapeutics Inc. SMMT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 164.00% | 131.87% | 65.71% | 73.02% | -51.01% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 303.44% | 167.74% | 92.49% | -40.98% | 214.98% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -1.56% | -0.63% | -0.63% | -2.77% | -0.62% |
| Total Current Assets | 168.08% | 133.02% | 66.31% | 69.98% | -49.73% |
|
|
|||||
| Total Current Assets | 168.08% | 133.02% | 66.31% | 69.98% | -49.73% |
| Net Property, Plant & Equipment | 240.11% | 239.49% | 200.76% | 192.98% | -24.40% |
| Long-term Investments | -1.20% | -3.48% | 2.18% | 7.35% | 0.40% |
| Goodwill | -1.20% | -3.48% | 2.18% | 7.35% | 0.40% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 27.35% | 29.65% | 98.58% | 182.77% | 201.89% |
| Total Assets | 164.72% | 132.13% | 68.79% | 72.46% | -47.95% |
|
|
|||||
| Total Accounts Payable | 47.07% | -0.37% | 451.64% | 337.70% | 584.04% |
| Total Accrued Expenses | 89.00% | 127.54% | 100.89% | 49.14% | 43.76% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 41.51% | 13.86% | -10.27% | -10.01% | -90.39% |
| Total Finance Division Other Current Liabilities | -6.54% | 76.57% | 51.25% | 27.05% | 90.46% |
| Total Other Current Liabilities | -6.54% | 76.57% | 51.25% | 27.05% | 90.46% |
| Total Current Liabilities | 69.77% | 71.68% | 138.74% | 74.91% | 10.03% |
|
|
|||||
| Total Current Liabilities | 69.77% | 71.68% | 138.74% | 74.91% | 10.03% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 495.75% | 591.33% | 479.94% | 406.86% | -35.63% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -1.20% | -1.96% | 5.33% | 12.39% | 6.64% |
| Total Liabilities | 84.50% | 89.17% | 158.09% | 97.22% | 6.98% |
|
|
|||||
| Common Stock & APIC | 53.09% | 58.26% | 86.66% | 84.08% | 42.44% |
| Retained Earnings | -40.13% | -46.45% | -94.41% | -88.89% | -79.91% |
| Treasury Stock & Other | 0.41% | 3.16% | -2.69% | -11.16% | -17.37% |
| Total Common Equity | 193.70% | 142.83% | 58.55% | 69.48% | -56.10% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 193.70% | 142.83% | 58.55% | 69.48% | -56.10% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 193.70% | 142.83% | 58.55% | 69.48% | -56.10% |
|
|
|||||